United States · Series A startup

Who invested in DeepCure

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

AI

Funding summaryUpdated 26 Oct 2026

$25Mraised across 1 round since 2024, from 1 source

Latest round
Series A, $25MApr 2024
Investors
5
See who backed them

The rounds

  1. Apr 2024

Founders and team

From DeepCure's own website: 2 founders, 7 on the team.

Kfir SchreiberCEO & Co-Founder
Joseph JacobsonCo-Founder
  • Han LimChief Business Officer
  • Luca RastelliChief Scientific Officer
  • Derek MillerVP, Head of Platform Research
  • Ehsan JabbarzadehDirector
  • Gerald ChanDirector
  • Jason DingesDirector
  • Shahar TzafrirDirector

Everyone who backed them

Creative Destruction LabAccelerator1round
Morningside GroupVC firm1round
The E14 FundVC firm1round
IAG Capital PartnersPrivate equity1round
TLV Partnersno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about DeepCure

Who invested in DeepCure?

DeepCure's investors include Creative Destruction Lab, Morningside Group, The E14 Fund, IAG Capital Partners and TLV Partners.

How much has DeepCure raised?

DeepCure has raised $25M across 1 round since 2024.

When did DeepCure last raise?

DeepCure's most recent round was a Series A of $25M in Apr 2024.

What was DeepCure's biggest round?

Its most recent round, $25M in Apr 2024, is also its largest on record.

Who backed DeepCure first?

DeepCure's first round on record, in Apr 2024, was backed by Creative Destruction Lab, Morningside Group and The E14 Fund and 2 others.

What stage is DeepCure at?

DeepCure's latest named round is a Series A, in Apr 2024.

Where is DeepCure based?

DeepCure is based in the United States.

Companies like DeepCure

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.